MedPath

Take control! Evaluation of a novel training to improve self-control in tobacco dependence

Phase 2
Conditions
Tobacco dependence
Registration Number
DRKS00014652
Lead Sponsor
niversitätsklinikum Hamburg-Eppendorf Arbeitsgruppe Neuroplastizität
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
122
Inclusion Criteria

age 18-70 years
- CO = 10 ppm
- FTND = 3
- non-usage of nicotine replacement therapy (NRT) and e-cigarettes
- no pharmacological or psychotherapeutic smoking cessation intervention
- non-usage NRT, e-cigarettes and other smoking cessation interventions during study participation

Exclusion Criteria

- severe neurological disorder (Parkinson, mulitple sclerosis)
- severe psychiatric disorder (e.g. bipolar disorder, schizophrenia)
- Acute Suicidality
- Substance dependence (except tobacco) within the last 12 months
- pregnancy or nursing
- insuffucient knowledge of German language

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Outcome:<br>Reduction of daily cigarette consumption from pre to post (Interval:4 Wochen).<br>Process:<br>Improvement of inhibition/self-control from pre to post (interval: 4 weeks). Both general and disorder-specific inhibition will be used.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath